Oscor plans Florida expansion; Rep. Bilbray introduces bill to repeal device tax;

> Cardiac devicemaker Oscor, which currently employs about 195 people, plans to add 70 more jobs to its headcount as the company expands in Pinellas County, FL. Report

> Congressman Brian Bilbray (R-San Diego) has introduced the Medical Device Tax Repeal Bill, H.R. 5615, designed to repeal the medical device manufacturing tax that was passed with President Barack Obama's health care insurance bill earlier this year. Story 

>  St. Jude Medical has completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash. Release

> Hologic has entered into a definitive agreement to acquire Sentinelle Medical, a leading provider of Magnetic Resonance Imaging (MRI) breast coils, tables and visualization software. Release

> Reverse Medical Corporation has received CE Mark for its RePort Guide Catheter System, intended to provide intracranial access during interventional neurovascular procedures. Release

> RepRegen has received CE marking approval for StronBone bioactive glass with Strontium, the first product that will be commercialized from RepRegen's repair-and-regeneration platform of ‘smart' biomaterials for hard tissue, such as bone. Release

> Cambridge Heart has announced the first patient enrollments in the MTWA-CAD study (Evaluation of Microvolt T-Wave Alternans Testing for the Detection of Active Ischemia in Patients with Known or Suspected Coronary Artery Disease). Release

> Biomagnetics Diagnostics, a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, has signed a new CRADA with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens. Release

> HP Enterprise Services has signed a seven-year outsourcing agreement with Smith & Nephew, the medical devices specialist. The deal is for finance and administration business process outsourcing services agreement that will support the finance transformation by improving productivity, enhancing quality and providing increased operating flexibility. Report

> Massachusetts-based Arrhythmia Research Technology has purchased medical device and IT provider RMDDx. ART makes signal-averaging electrocardiography software for detecting heart arrhythmias. News

> Crux Biomedical has successfully enrolled the first patient in its Retrieve 2 pivotal U.S. IDE trial. Release

> Alcon has entered into a definitive agreement to acquire LenSx Lasers, Inc, a privately held company that developed the first femtosecond laser to receive FDA clearance for use as a part of cataract surgery. The LenSx system is indicated for anterior capsulotomy and laser phacofragmentation during cataract surgery, providing a complementary surgical approach to certain manual steps within the traditional cataract procedure. Release

> Low-tech pregnancy device might help birth attendants reduce maternal mortality. Article

And Finally... With the help of a $33 million golden handshake, former Schering-Plough head Fred Hassan bypassed perennial top dogs Bill Weldon (Johnson & Johnson) and Miles White (Abbott) as the highest-paid CEO in Pharma, a report on the top 10 Pharma CEO salaries reveals. Report

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.